KOROUSH KHALIGHI, M.D.

Plain English
This study looked at how sensitive critically ill patients are to warfarin, a common blood thinner, and how this sensitivity affects their chances of dying while in the hospital. Researchers tested various machine learning methods and found that one particularly effective approach predicted warfarin sensitivity well. They discovered that patients who were sensitive to warfarin had a 33% higher risk of in-hospital death compared to those who were not sensitive. Who this helps: This research helps doctors better manage warfarin treatment for critically ill patients.

Plain English
This study looked at the relationship between vitamin D levels and various blood fats and proteins in 101 patients. It found that people with low vitamin D (under 30 ng/ml) had higher levels of bad cholesterol (LDL) and other harmful fat particles, while those with normal vitamin D levels had better levels of good cholesterol (HDL). These findings highlight that low vitamin D may increase the risk of heart disease due to unhealthy fat levels in the blood. Who this helps: This helps patients at risk for heart disease and their doctors.

Plain English
This study investigated how well a new algorithm (PARAD+) can reduce inappropriate defibrillator shocks in patients who received implanted devices to prevent sudden cardiac arrest. Out of 993 patients monitored, 98.1% did not experience any inappropriate shocks over two years, with a low annual incidence rate of 1.0 to 2.1 cases per 100 individuals. This is significant because it suggests the algorithm effectively lowers the occurrence of unnecessary shocks, which can be distressing for patients. Who this helps: This helps patients with implantable defibrillators.

Plain English
This study looked at how certain gene variations (called polymorphisms) might relate to cholesterol levels in 318 patients. It found that individuals with one specific gene variant (denoted by 'variants') had lower levels of good cholesterol (HDL) compared to those without this variant (50.9 vs 47.1). This matters because lower HDL levels can increase the risk of heart disease, so understanding these genetic factors could help in managing health risks. Who this helps: Patients at risk for heart disease.

Plain English
This study looked at a 49-year-old woman who had an incredibly high triglyceride level of more than 10,000 mg/dL, which is extremely rare for someone not experiencing pancreatitis. Typically, triglyceride levels above 2,000 mg/dL are uncommon, and high levels can lead to serious health issues. The findings emphasize the importance of quickly lowering triglyceride levels and managing any conditions that could lead to these high numbers to avoid health risks. Who this helps: This helps doctors and healthcare providers in managing patients with extremely high triglyceride levels.

Plain English
This study focused on how genetics affect people's sensitivity to warfarin, a common blood-thinning medication. Researchers found that 95.1% of Black patients responded normally to warfarin, while 74.8% of Asian patients were sensitive to it, highlighting significant differences in drug response linked to ethnicity. They developed a clinical tool that predicts how individuals will respond to warfarin based on their genetic makeup, which outperformed traditional dosing methods and has the potential to improve treatment and outcomes for patients needing this medication. Who this helps: This helps patients who require warfarin therapy, especially those with varying genetic backgrounds.

Plain English
This study focused on a type of blood clot found in the descending thoracic aorta, which can lead to serious health issues like damage to organs and limbs. The researchers presented a case where a 65-year-old woman’s clot was discovered by chance during a CT scan, and after being treated with blood thinners, she avoided serious complications. It’s important to recognize these clots early to prevent further health problems. Who this helps: Patients with aortic blood clots and their doctors.

Plain English
This study looked at two specific gene variations (or polymorphisms) related to the MTHFR gene and how they affect inflammation in the body, which can lead to various diseases. They found that patients with the MTHFR C677T variant had higher levels of inflammation (measured by the neutrophil-to-lymphocyte ratio) compared to those without this variant (3.77 vs. 3.06), while those with the MTHFR A1298C variant had lower levels of inflammation (3.21 vs. 3.79). Understanding these differences matters because it could help explain how these genetic factors lead to diseases such as diabetes and heart disease. Who this helps: This helps patients and doctors by providing insights into the genetic risks for inflammatory diseases.

Plain English
This study looked at how to improve the success rate of electrical cardioversion, a procedure used to restore normal heart rhythm in patients with atrial fibrillation. It focused on three patients with a higher body weight and large chest sizes, who initially did not respond to the standard cardioversion technique. By using a special imaging method called fluoroscopy to accurately position the electrode pads, the success of restoring normal heart rhythm increased significantly. Who this helps: This benefits patients with atrial fibrillation, especially those who are larger or have difficulty with standard cardioversion methods.

Plain English
This study looked at a 77-year-old woman with a rare heart condition called dextrocardia and ongoing atrial fibrillation (AF), which had not been controlled by medications. After a challenging procedure to ablate the AV node and place a pacemaker, her symptoms significantly improved within 24 hours. This is important because it shows that this treatment can help patients with difficult heart conditions who can't use traditional therapies. Who this helps: This benefits patients with atrial fibrillation and complex heart structures.

Plain English
This study looked at the safety and complications of a device called the Watchman, which helps prevent blood clots in patients with a heart condition called nonvalvular atrial fibrillation who can't take long-term blood thinners. The researchers followed 48 patients in two community hospitals and found that 98% of the procedures were successful, with no complications related to the implanting of the device. At the 45-day mark, only 4% of patients had issues with clot formation on the device, indicating that it can be safely used in local hospitals. Who this helps: This benefits patients with nonvalvular atrial fibrillation who need an alternative to long-term blood thinners.

Plain English
This study looked at how elevated troponin levels in patients with suspected septicemia and certain heart conditions, specifically left bundle branch block, impact treatment decisions. Researchers found that many patients with high troponin don’t always get urgent heart procedures even when they show signs of serious heart issues, which could lead to missed diagnoses. This is particularly concerning for women and patients with specific heart block conditions. Who this helps: This benefits both patients experiencing atypical chest pain and doctors identifying high-risk cases.

Plain English
This study looked at improving how doctors determine the right dose of warfarin, a medication used to prevent blood clots, by using advanced machine learning techniques. The new algorithms showed better results than the current standard method, with a 12.7% improvement in accurately predicting doses for Asian patients and a 13.5% improvement for patients who need lower doses. These improvements are important because getting the warfarin dose right is crucial to avoid serious problems like excessive bleeding or blood clots. Who this helps: This helps patients who require warfarin, especially those needing lower doses, and their doctors.

Plain English
This study focused on a 19-year-old man whose left main coronary artery was improperly positioned, leading to fainting and a heart attack. The researchers emphasized that this rare condition is critical to recognize in young patients experiencing similar heart problems, as timely diagnosis and surgery can prevent serious complications. Early identification can significantly improve outcomes for patients with this type of heart anomaly. Who this helps: This research assists young patients with abnormal heart conditions and their doctors.

Plain English
This study examined how specific genetic variations in three genes (VKORC1, CYP2C9, and CYP2C19) affect the required dose of warfarin, a common blood thinner, in 492 patients. The research found that people with certain gene variations (like VKORC1-1639 G>A and CYP2C9*2, *3) needed lower doses of warfarin, while those with specific CYP2C19 genotypes generally required higher doses. Understanding these genetic influences is crucial because it can lead to more personalized and effective warfarin treatments, reducing the risk of complications. Who this helps: This helps patients who need warfarin therapy by tailoring their treatment based on genetic testing.

Plain English
This study looked at a way to prevent strokes in patients with atrial fibrillation (AF) who can't take blood thinners because of bleeding risks. Researchers focused on a medical device called the Watchman, which aims to reduce the risk of blood clots. They reported successful placement of this device in three patients, demonstrating its effectiveness as a non-drug alternative. Who this helps: This benefits patients with atrial fibrillation who cannot use anticoagulants.

Plain English
This study looked at a rare heart condition called apical hypertrophic cardiomyopathy (AHCM), which mainly affects the lower portion of the heart's left ventricle. Researchers reported on a 46-year-old woman who suffered from severe shortness of breath and had signs of significant heart wall thickening, including a very high pressure measurement of at least 160 mmHg in her heart. After treatment with specific medications, she has remained symptom-free for over two and a half years. Who this helps: This information benefits patients with heart conditions, especially those showing unexplained respiratory issues and abnormal ECG results.

Plain English
This study looked at a specific case where a patient developed a deep vein clot while taking apixaban, a medication used to prevent blood clots. Despite its effectiveness in most patients, this case shows that some individuals may not respond to the medication as expected. Understanding these rare occurrences is crucial as it highlights the need for individualized treatment approaches in managing patients at risk of blood clots. Who this helps: This helps patients at risk of blood clots and their doctors.

Plain English
This study examined how genetic differences in the CYP2C19 enzyme affect the effectiveness of clopidogrel, a medication used to prevent blood clots in patients with heart conditions. Among 465 patients, about 19% had variations that made them "slow" or "fast" metabolizers of the drug. By tailoring clopidogrel prescriptions based on these genetic results, doctors improved outcomes for slow metabolizers and reduced bleeding risks for fast metabolizers. Who this helps: This helps patients with cardiovascular disease by ensuring they receive the most effective medication for their genetic profile.

Plain English
This study focused on a 29-year-old man with sarcoidosis who experienced symptoms like weight loss, fatigue, and heart palpitations. Doctors found that his heart was affected, even though only 5% of sarcoidosis patients are diagnosed with cardiac involvement; however, autopsies show up to 30% might actually have heart issues without knowing it. Recognizing heart problems in sarcoidosis patients quickly is important to prevent serious risks, including sudden death, and new imaging techniques can help identify these issues earlier. Who this helps: This helps patients with sarcoidosis and their doctors.

Plain English
This study examined whether a new type of X-ray technology, called Allura Clarity, could lower radiation exposure for patients undergoing procedures in an electrophysiology lab. Researchers analyzed the radiation doses of 90 patients and found that the new technology significantly reduced exposure during procedures like inserting watchman devices, performing radiofrequency ablation, and placing pacemakers or defibrillators. This is important because it helps protect patients from harmful radiation while still allowing essential medical procedures to take place. Who this helps: This benefits patients undergoing heart-related procedures.

Plain English
This research focused on a 45-year-old woman who experienced chest pain that seemed to be a heart issue but was actually caused by Lyme disease. Despite high levels of cardiac markers indicating heart stress (Troponin I rose from 7.82 ng/mL to 13.44 ng/mL), tests showed no blocked arteries. The patient was diagnosed with Lyme disease, treated successfully, and her symptoms and heart function returned to normal, highlighting how Lyme disease can be mistaken for heart problems, which is important for accurate diagnosis and treatment. Who this helps: This helps patients, particularly those with chest pain and risk factors for heart disease, by ensuring Lyme disease is considered in their diagnosis.

Plain English
This study looked at Takotsubo Cardiomyopathy (TC), a condition where the heart suddenly weakens, often triggered by stress. The researchers found that patients who reduced their risk factors, such as high blood pressure and cholesterol, improved significantly over a long-term follow-up, although specific improvement numbers weren't given. Understanding how to manage these risk factors is important because it can lead to better outcomes for patients with TC. Who this helps: Patients with Takotsubo Cardiomyopathy and their doctors.

Plain English
This study looked at a condition called Wellens' syndrome, which shows specific changes in heart EKG readings when a patient isn't experiencing chest pain. The researchers presented a case of an overweight man who had chest pain and was found to have significant blockages in his heart arteries. After treatment, a follow-up EKG showed different changes that indicated his heart was getting the blood it needed, highlighting the importance for doctors to recognize these patterns to prevent serious heart attacks. Who this helps: This information helps doctors who treat patients with heart issues.

Plain English
This study looked at the heart problems that can arise in people with myotonic dystrophy, a rare muscle disorder. Out of nine patients examined, eight showed heart conduction issues on their EKGs, and five needed immediate treatment for dangerous heart rhythms. Since sudden heart-related deaths can happen in one-third of these patients, it’s crucial to spot those at risk and provide preventive care. Who this helps: This helps patients with myotonic dystrophy and their doctors by identifying those at risk of serious heart problems.

Plain English
This study looked at two elderly women who developed low sodium levels (hyponatremia) after getting pacemakers. Both women had complications from fluid buildup around the heart (pericardial effusion) and experienced significant symptoms, with their sodium levels dropping to 116 and 119 mEq/dl. The findings are important because they highlight that this rare condition can occur in petite older women after a pacemaker procedure and emphasize the need for quick diagnosis and treatment to improve their health outcomes. Who this helps: This helps elderly patients and their doctors by raising awareness of potential complications after pacemaker surgery.

Plain English
This paper studied Brugada syndrome (BrS), a genetic heart condition that affects how electrical signals control the heartbeat. Researchers highlighted that patients with BrS can experience serious heart rhythm problems, especially when they have a fever or take specific medications; for example, one 26-year-old patient showed dangerous EKG changes linked to his fever and past fainting episodes. Recognizing and treating BrS quickly is crucial, as it can lead to life-threatening situations; the best long-term treatment for patients is having an implantable defibrillator to prevent dangerous heart rhythms. Who this helps: This helps patients with Brugada syndrome and their doctors.

Plain English
This study looked at a rare case of a 67-year-old woman who developed an infection from a fungus called Aspergillus fumigatus after having a pacemaker for 15 years. Doctors found the infection when she had a lump in her chest, and after draining fluid and testing it, they discovered the fungus. She received the right treatment, which included removing the pacemaker and taking antifungal medication, and she recovered well. Who this helps: This information benefits doctors and patients with cardiac devices by raising awareness about potential fungal infections, even in healthy individuals.

Plain English
This study looked at how managing risk factors affects the long-term health of women diagnosed with Takotsubo Cardiomyopathy (TC). Researchers followed 12 patients for an average of 8.3 years after they received care that included lifestyle changes and medications. The findings showed no patients died or experienced a recurrence of TC, suggesting that these management strategies are important for improving outcomes in TC patients. Who this helps: This helps patients with Takotsubo Cardiomyopathy.

Plain English
This study looked at the effectiveness of applying topical antibiotics during cardiac device surgeries to prevent infections. Out of 1,008 patients, 58 developed infections, with 14 having positive cultures, mostly from a type of bacteria called Staphylococcus. The findings highlight that using topical antibiotics does not significantly lower infection rates, especially in patients with longer surgery times or those with cancer, underscoring the importance of using systemic antibiotics for better protection against infections. Who this helps: This helps patients undergoing cardiac device surgeries and their healthcare providers.

Plain English
This study looked at the use of implantable cardioverter defibrillators (ICDs) in a community hospital, reviewing cases to establish clear guidelines for who should receive these devices. The researchers analyzed 13 specific cases to define when ICDs are appropriate, including for patients at risk of sudden cardiac death and those with heart failure. By creating standardized criteria for device use, the hospital can provide better care while also managing costs and resources effectively. Who this helps: This benefits patients at risk of heart issues and their doctors.

Plain English
This study looked at whether a type of pacemaker that adjusts the heart rate during activity (rate-modulated pacing) can improve the quality of life and exercise capacity of patients who need a pacemaker. Researchers found that while patients using the rate-modulated pacing had a higher peak heart rate during exercise (113.3 beats per minute compared to 101.1 for those without modulation), there were no noticeable improvements in overall quality of life or functional status after a year. This matters because it suggests that the additional feature in most pacemakers may not provide the expected benefits for patients with bradycardia. Who this helps: This helps patients with pacemakers and their doctors in understanding the effectiveness of pacing options.

Plain English
This study looked at how effective a treatment called antitachycardia pacing (ATP) is for patients with fast heartbeats, compared to electric shocks, in patients who have a device called an implantable cardioverter-defibrillator (ICD). Researchers tracked 634 patients and found that ATP successfully stopped 81% of fast heart episodes without causing pain from shocks, while both treatments had similar safety outcomes. This is important because using ATP can reduce discomfort for patients and improve their quality of life. Who this helps: This helps patients with implantable cardioverter-defibrillators experiencing fast heartbeats.

Plain English
This study focused on two patients who experienced seizures that were actually caused by their hearts temporarily stopping (called cardiac asystole). Both had an issue with their heart's natural pacemaker, leading to these misleading seizure-like episodes. After being given pacemakers, the seizures stopped completely, highlighting the need to monitor heart function in patients with seizure symptoms. Who this helps: This benefits patients who have unexplained seizure episodes, as well as doctors diagnosing these cases.

Plain English
This study looked at how well temporary pacing wires work in patients after they have open heart surgery. Researchers tracked 60 patients for about 5 days and found that the effectiveness of these wires decreased each day, with key measurements showing significant drops by the second and fourth days after surgery. This decline in function highlights the need for careful monitoring of patients with these devices to ensure their hearts are properly paced after surgery. Who this helps: This helps doctors and healthcare teams manage care for patients recovering from heart surgery.

Plain English
This study compared two types of leads used in implantable defibrillators to see how often they fail. Out of 247 patients, 18% (19 out of 107) of those with the BT-10 leads experienced lead failures, while only 4% (6 out of 140) of those with the Endotak leads faced similar issues. This matters because lead failures can lead to unnecessary shocks, affecting patient safety, and shows that the Endotak leads are more reliable over time. Who this helps: Patients with implantable defibrillators and their doctors.

Plain English
This study examined how patients respond after a procedure called radiofrequency ablation, which targets the AV node to treat certain heart rhythm problems. Researchers looked at 24 patients and found that although some had low heartbeats right after the procedure, most developed a stable and adequate heart rhythm within 12 hours, with 3 out of 4 previously having low heart rates improving. This is important because knowing how patients recover can help doctors manage risks associated with heart rhythms and device issues. Who this helps: This helps patients undergoing radiofrequency ablation and their doctors by improving understanding of recovery patterns.

Plain English
This study examined a rare medical condition called paradoxical embolism, where a blood clot travels through a hole in the heart (patent foramen ovale or PFO) and affects multiple organs at once. In one case, a patient experienced issues in the brain, left arm, and coronary artery along with acute pulmonary embolism. The patient was quickly diagnosed using a special heart imaging test and treated effectively, highlighting the importance of checking for PFO in patients with blood clots. Who this helps: This benefits patients with pulmonary embolism or deep vein thrombosis by improving diagnosis and treatment options.

Plain English
This study looked at a new way to treat abdominal aortic aneurysms in patients whose blood vessel structure made traditional methods risky. Researchers successfully used a special type of stent in seven patients, and follow-up tests over an average of just over 10 months showed that their kidney function remained normal and the aneurysms were effectively treated. This matters because it means that patients with difficult-to-treat aneurysms may have a safer treatment option that protects their kidney function. Who this helps: This helps patients with abdominal aortic aneurysms who have short blood vessel necks.

Plain English
This study introduced a new way to insert suturing devices into groins that have a lot of scar tissue by using a special tool called a peel-away sheath. This tool makes it easier to keep the device in place, allowing doctors to successfully close up arteries without having to stop the procedure. This method can prevent complications in cases where traditional techniques might fail. Who this helps: This benefits patients with severe scarring in their groin area.

Plain English
This research looked at using a silicon sheet to temporarily cover wounds in patients who had surgery for a condition called compartment syndrome. Out of 18 surgeries performed on 17 patients, the silicon sheet was used in 9 cases, and it worked well—6 patients healed without any complications, and there was only one infection. This method is important because it leads to lower costs, less pain during dressing changes, and better healing results for patients. Who this helps: This helps patients recovering from compartment syndrome surgery.

Plain English
This study looked at how adding a special type of electrode under the skin affects the amount of energy needed to shock the heart back into a normal rhythm. Researchers found that using this additional electrode lowered the energy needed to successfully defibrillate the heart from an average of 9.5 joules to just 5.7 joules, and the setup did not cause any complications during over 15 months of follow-up. This is important because it means patients might require less energy for defibrillation, making the procedure safer and potentially more effective. Who this helps: This benefits patients who need heart defibrillation, especially those at risk for sudden cardiac issues.

Plain English
This study looked at how certain clinical factors can predict the energy needed for Transvenous Defibrillation in patients getting an implantable cardioverter-defibrillator (ICD). Researchers found that 76% of the 119 patients achieved an adequate defibrillation energy requirement of 20 joules or less. Key factors indicating a higher energy requirement included being treated with amiodarone, having left ventricular dilation, and a patient's body size, with 69% of those with the highest risk factors needing higher energy levels. Who this helps: This information benefits patients receiving ICDs, as it helps doctors better understand energy requirements for their treatment.

Plain English
This study looked at how the amount of energy needed to successfully reset the heart with a defibrillator changed over time in 31 patients with a specific type of heart lead system. After about 9 months, the energy levels required increased by 26%, going from an average of 13.2 joules to 17.1 joules. These findings are important because they indicate that over time, patients may need more energy for defibrillation, which could impact their treatment and safety. Who this helps: This helps patients with heart conditions and their doctors by informing treatment strategies.

Plain English
Researchers studied how defibrillator shocks affect heart signals in three patients with specific defibrillator systems. They found that after the shocks, the readings of heart electrical activity were significantly distorted, which looked like a different heart problem called ventricular tachycardia. Understanding this distortion is important for correctly diagnosing heart rhythm issues in patients. Who this helps: This helps doctors who treat patients with atrial arrhythmias and use defibrillators.

Plain English
This study examined what factors predict effective defibrillation in patients receiving a specific type of heart device called a cardioverter-defibrillator. The researchers found that 92% of the 114 patients achieved an adequate defibrillation energy level (20 Joules or less), and that two main factors—how enlarged the heart's left ventricle was and the patient's body size—were linked to higher energy requirements for successful defibrillation. Specifically, patients with a normal heart size had no issues, while 14% of those with enlarged hearts needed more energy to defibrillate successfully. Who this helps: This research benefits patients with heart conditions who are receiving defibrillator implants.

Plain English
This study looked at the effectiveness of two types of heart medications (class Ia/Ib and class III) for treating a dangerous heart rhythm called sustained ventricular tachycardia in patients with coronary artery disease. Researchers found that only 13% of patients responded to the Ia/Ib drugs, while 19% responded to class III drugs, but this difference wasn’t significant. Notably, patients with heart failure had a much lower response rate to the Ia/Ib drugs (8%) compared to class III drugs (59%), indicating that heart failure makes these drugs less effective. Who this helps: This research helps patients with coronary artery disease and heart failure by guiding doctors on which treatments may work best for them.

Plain English
This study tested a new type of electrode used in defibrillation for patients who need a lot of energy to correct their heart rhythm. Researchers found that using the new single-element subcutaneous electrode significantly reduced the energy needed to defibrillate—down from 30 to 15 Joules for one patient and from 24 to 9 Joules for another. This matters because lower energy requirements during defibrillation can lead to safer and more effective treatments for patients. Who this helps: This helps patients with high defibrillation thresholds.

Plain English
This study looked at the quality of blood collected from patients' chest drains after heart surgery and how well it could be reused safely. Researchers tested blood from 20 patients and found significant changes in blood cells and high activity in the blood's clotting factors, especially in patients with low blood loss. They concluded that if this blood is reused, it should only be within the first four hours after surgery for those who lost a lot of blood. Who this helps: This research benefits heart surgery patients by providing guidelines for safe blood reuse.